Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GEO accession GSE284421 is currently private and is scheduled to be released on Dec 31, 2025.

ABSTRACT: GEO accession GSE284421 is currently private and is scheduled to be released on Dec 31, 2025.

PROVIDER: PRJNA1198991 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

The effect of CLEC16A in Dendritic Cells (Single Cells)

Project description:CLEC16A were conditionally knocked out in Dendritic Cells, and the dendritic cells were sorted out using FACS and 10X single cell RNA-Seq protocol was used to profiled the transcriptome of individual cells.

2025-12-31 | GSE284421 | GEO

Effect of nociceptors on dendritic cells

Project description:Effect of nociceptors on dendritic cells

| PRJNA899115 | ENA

Clec16a maintains the Definitive Hematopoietic Stem and Progenitor Cells via Mitophagy in Zebrafish

Project description:Since clec16a signaling is imperative for HSPCs production in zebrafish, to further determine the regulatory mechanism by which clec16a signaling regulates HSPCs. Bulk RNA sequencing analysis is performed to dissect the function and molecular mechanism between the control groups and the clec16a morphants groups.

2026-01-06 | GSE281435 | GEO

Effect of nociceptive neuropeptides on dendritic cells

Project description:Effect of nociceptive neuropeptides on dendritic cells

| PRJNA899116 | ENA

CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse model [Single Cell Dataset]

Project description:Astrocytes promote neuroinflammation and neurodegeneration in multiple sclerosis (MS) through cell-intrinsic activities and their ability to recruit and activate other cell types. Here, in a genome-wide CRISPR-based forward genetic screen investigating regulators of astrocyte proinflammatory responses, we identified the C-type lectin domain-containing 16A gene (CLEC16A), linked to MS susceptibility, as a suppressor of nuclear factor-κB (NF-κB) signaling. Gene and small-molecule perturbation studies in mouse primary and human embryonic stem cell-derived astrocytes in combination with mitochodrial, metabolic and multiomic analyses established that CLEC16A promotes mitophagy, limiting mitochondrial dysfunction and the accumulation of mitochondrial products that activate NF-κB, the NLRP3 inflammasome and gasdermin D. Astrocyte-specific Clec16a inactivation increased NF-κB, NLRP3 and gasdermin D activation in vivo, worsening experimental autoimmune encephalomyelitis, a mouse model of MS. Moreover, we detected disrupted mitophagic capacity and gasdermin D activation in astrocytes in samples from individuals with MS. These findings identify CLEC16A as a suppressor of astrocyte pathological responses and a candidate therapeutic target in MS. Scheduled for publication in Nature Neuroscience DOI: 10.1038/s41593-025-01875-9

2024-12-03 | GSE283395 | GEO

Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine

Project description:This study is being conducted to determine the efficacy, side effects, and toxicity of an investigational vaccine that consists of tumor-pulsed dendritic cells administered with an immune stimulating drug called interleukin-2 (IL-2). Dendritic cells are immune cells that are obtained from a subject’s blood and are important in the body’s immune response to foreign substances. This study will examine the response of a subject’s immune system after receiving several vaccinations containing their own dendritic cells which have been exposed to dead fragments of their cancer cells in the laboratory. This may result in sensitizing a subject’s dendritic cells to their cancer cells so that their dendritic cells will react with other cells of the immune system and attack the cancer. It has been shown in the laboratory that dendritic cells exposed to cancer cell fragments can provide lymphocytes (a type of white blood cell) with signals they require in order to become fully activated and acquire the ability to kill cancer cells.

| 2017769 | ecrin-mdr-crc

CRISPR screen identified CLEC16A suppresses astrocyte inflammasome-involved pathology via mitophagy: EAE study

Project description:CLEC16A conditional knockout using GFAP-Cre

2023-11-09 | GSE189029 | GEO

Effect of depletion of Zeb1 in CD11c+ dendritic cells

Project description:Effect of depletion of Zeb1 in CD11c+ dendritic cells

| PRJNA891854 | ENA

Single-cell RNA-seq of human blood dendritic cells from buffy coats and in vitro differentiated dendritic cells from cord blood CD34 + stem cells

Project description:To compare human dendritic cells from peripheral blood, in vitro cultures with dendritic cells from human tumor tissues in publicly available single-cell RNA-seq datasets we performed single-cell RNA-seq of human blood dendritic cells and in vitro differentiated dendritic cells from cord blood CD34 + stem cells

2022-06-15 | E-MTAB-11735 | biostudies-arrayexpress

CRIPSR screen identified CLEC16A suppresses astrocyte inflammasome-involved pathology via mitophagy: human in vitro study

Project description:CLEC16A knocked down human embryonic stem cell (hESC) derived astrocytes

2023-11-09 | GSE189028 | GEO